Frelin; Lars
Patent Applications and Registrations
Patent applications and USPTO patent grants for Frelin; Lars.The latest application filed is for "chimeric antigen receptors directed to cells expressing the sodium taurocholate co-transporting receptor".
- Frelin; Lars - Stockholm SE
- Frelin; Lars - Alvsjo SE
- Frelin; Lars - Tullinge SE
- Frelin; Lars - Tumba SE
| Patent | Date |
|---|---|
| Chimeric Antigen Receptors Directed To Cells Expressing The Sodium Taurocholate Co-transporting Receptor App 20220152108 - Sallberg; Matti ; et al. | 2022-05-19 |
| Chimeric Hepatitis D Virus Antigen And Hepatitis B Virus Pre S1 Genes For Use Alone Or In Vaccines Contaning Hepatitis B Virus Genes App 20210236626 - Sallberg; Matti ; et al. | 2021-08-05 |
| Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines containing hepatitis B virus genes Grant 10,905,760 - Sallberg , et al. February 2, 2 | 2021-02-02 |
| Chimeric Hepatitis D Virus Antigen And Hepatitis B Virus Pre S1 Genes For Use Alone Or In Vaccines Contaning Hepatitis B Virus Genes App 20190083607 - Sallberg; Matti ; et al. | 2019-03-21 |
| Injection Needle And Device App 20170216573 - Sallberg; Matti ; et al. | 2017-08-03 |
| Immunogen Platform App 20170058003 - Sallberg; Matti ; et al. | 2017-03-02 |
| Immunogenic Compositions For Inhibiting Hepatitis D Virus App 20160324954 - Sallberg; Matti ; et al. | 2016-11-10 |
| Injection needle and device Grant 9,457,183 - Sallberg , et al. October 4, 2 | 2016-10-04 |
| Injection Needle And Device App 20160235928 - Sallberg; Matti ; et al. | 2016-08-18 |
| Treatment Of Hepatitis D Virus Infections By Redirection Of T Cells App 20160228531 - Sallberg; Matti ; et al. | 2016-08-11 |
| Simple Vaccines From Dna Launched Suicidal Flaviviruses App 20160215023 - Sallberg; Matti ; et al. | 2016-07-28 |
| Compositions And Methods That Enhance An Immune Response App 20150252084 - Sallberg; Matti ; et al. | 2015-09-10 |
| Immunogen Platform App 20150051388 - Sallberg; Matti ; et al. | 2015-02-19 |
| Immunogen platform Grant 8,883,169 - Sallberg , et al. November 11, 2 | 2014-11-11 |
| Simple Vaccines From Dna Launched Suicidal Flaviviruses App 20140286985 - Sallberg; Matti ; et al. | 2014-09-25 |
| Injection Needle And Device App 20140121587 - Sallberg; Matti ; et al. | 2014-05-01 |
| Compositions And Methods That Enhance An Immune Response App 20130202554 - SALLBERG; MATTI ; et al. | 2013-08-08 |
| Compositions and methods that enhance an immune response Grant 8,445,663 - Sallberg , et al. May 21, 2 | 2013-05-21 |
| Codon-optimzed Hepatitis B Virus Core Antigen (hbcag) App 20130012865 - Sallberg; Matti ; et al. | 2013-01-10 |
| Immunogen platform Grant 8,258,275 - Sallberg , et al. September 4, 2 | 2012-09-04 |
| Compositions And Methods That Enhance An Immune Response App 20120039842 - Sallberg; Matti ; et al. | 2012-02-16 |
| Simple Vaccines From Dna Launched Suicidal Flaviviruses App 20120027795 - Sallberg; Matti ; et al. | 2012-02-02 |
| Immunogen Platform App 20120010394 - Sallberg; Matti ; et al. | 2012-01-12 |
| Immunogen platform Grant 8,071,561 - Sallberg , et al. December 6, 2 | 2011-12-06 |
| Immunogen Platform App 20110150922 - Sallberg; Matti ; et al. | 2011-06-23 |
| Immunogen Platform App 20090214593 - Sallberg; Matti ; et al. | 2009-08-27 |
| Transgenic mouse models of hepatitis C virus (HCV) and identification of HCV therapeutics Grant 7,566,812 - Sallberg , et al. July 28, 2 | 2009-07-28 |
| Transgenic Mouse Models of Hepatitis C Virus (Hcv) and Identification of Hvc Therapeutics App 20080295185 - Sallberg; Matti ; et al. | 2008-11-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 